Experienced in Patent Foramen Ovale

Shiho Suzuki

Mibu, JP 
Experienced in Patent Foramen Ovale
Mibu, JP 
OverviewLocationsClinical Research

Overview

Shiho Suzuki practices in Mibu, Japan. Ms. Suzuki is rated as an Experienced expert by MediFind in the treatment of Patent Foramen Ovale. Her top areas of expertise are Restless Legs Syndrome, Migraine, Headache, and Excessive Daytime Sleepiness.

Her clinical research consists of co-authoring 57 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 2 articles in the study of Patent Foramen Ovale.

Gender
Female

Locations

Mibu, 3210293, Japan
Other Locations
Tochigi, Japan
Kawasaki, 2148571, Japan
Japan
Tokyo, Japan
Hongo, 1130033, Japan
Kiryu, 3768515, Japan
Noda, Japan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

RandoMized, DOuble-bliNd, PlacebO-coNtrolled Trial Of Lasmiditan in a Single Migraine Attack in Japanese Patients SuFfering From Migraine With or WithoUt Aura - the MONONOFU Study
RandoMized, DOuble-bliNd, PlacebO-coNtrolled Trial Of Lasmiditan in a Single Migraine Attack in Japanese Patients SuFfering From Migraine With or WithoUt Aura - the MONONOFU Study
Enrollment Status: Completed
Publish Date: June 11, 2021
Intervention Type: Drug
Study Phase: Phase 2
A Randomized, Double-Blind, Placebo-Controlled Study of Galcanezumab in Adults With Treatment-Resistant Migraine - the CONQUER Study
A Randomized, Double-Blind, Placebo-Controlled Study of Galcanezumab in Adults With Treatment-Resistant Migraine - the CONQUER Study
Enrollment Status: Completed
Publish Date: July 08, 2020
Intervention Type: Drug
Study Phase: Phase 3
View 1 Less Clinical Trial

57 Total Publications

A real-world study of the efficacy and tolerability of fremanezumab in migraine patients with a median follow-up of 14 months.
A real-world study of the efficacy and tolerability of fremanezumab in migraine patients with a median follow-up of 14 months.
Journal: Neurological research and practice
Published: April 22, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Suzuki's expertise for a condition
ConditionClose
    View All 12 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile